Patent US3951719A successfully refreshed from Google Patents.
US4849207A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Porphyrin derivatives
Assignee: Photochemical Co Ltd
•
Filing: 1986-10-23
•
Granted: 1989-07-18
•
Expires: 2006-10-23
Abstract
Abstract A porphyrin compound of the formula: <IMAGE> (I) wherein R1 and R2 are each -CH=CH2, -CH2CH3, -CH(O-lower alkanoyl)CH3, -CH(OR)CH3 or -CH(O-lower alkylene-OR)CH3; R3 is -H, -COOH, -COO-lower alkyl, -COO-lower alkylene-OR or -COO-lower alkylene-OOC-Z; R4 is -H, -lower alkyl or -lower alkylene-OR; R is -H, -lower alkyl or a residue of a polyfunctional carboxyl compound excluding a hydrogen atom therefrom; Z is a residue of the compound of the formula (I) excluding R3 therefrom; A is -CH2- or -CO-; and the dotted line from the gamma-position indicates no bonding or a single direct bond; and the dotted line between the 7- and 8-positions indicates the presence of a single bond or a double bond; and its complexes with a metal(s) in the porphine skeleton and/or at the residue of the polyfuntional carboxyl compound, at least one of R1, R2, R3 and R4 being a group containing R which represents the residue of the polyfunctional carboxyl compound and R1 being capable of representing 1-iodoethyl in addition to said meanings when R3 is -COO-lower alkylene-OOC-Z, which shows a high accumulation in the locus of cancer with quick excretion from normal tissues.
Inventors
- 👤 Isao Sakata
- 👤 Susumu Nakajima
- 👤 Koichi Koshimizu
- 👤 Natsuki Samejima
- 👤 Kazumi Inohara
- 👤 Hiroyuki Takata
- 👤 Hirohiko Yamauchi
- 👤 Nobuo Ueda
- 👤 Masaaki Hazue
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 14:45
CPC Classifications
C; C07; C07D; C07D403/00; C07D403/14; C07D487/00; C07D487/22
Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
217 words
A porphyrin compound of formula: ##STR4## wherein R 1 and R 2 are each --CH═CH 2 , --CH 2 CH 3 , --CH(O-lower alkanoyl)CH 3 ; --CH(OR)CH 3 or --CH(O-lower alkylene-OR)CH 3 ; R 3 is --H, --COOH, --COO-lower alkyl, --COO-lower alkylene-OR or --COO-lower alkylene-OOC--Z; R 4 is --H, -lower alkyl or -lower alkylene-OR; R is --H, --lower alkyl or a residue of a polyfunctional compound, said polyfunctional compound containing as one functional group carboxyl and at least one additional functional group which is selected from the group consisting of amino; hydroxy; mercapto and carboxyl; Z is a residue of the compound of the formula (I) excluding R 3 therefrom; A is --CH 2 -- or --CO--; and the dotted line from the gamma-position indicates no bonding or a single direct bond; and the dotted line between the 7- and 8-positions indicates the presence of a single bond or a double bond; and its complexes with a metal(s) in the porphine skeleton and/or at the residue of the polyfunctional compound, at least one or R 1 , R 2 , R 3 and R 4 being a group containing R which represents the residue of the polyfunctional compound and R 1 being capable of representing 1-iodoethyl in addition to said meanings when R 3 is --COO-lower alkylene-OOC--Z.
Claim 2
Dependent Claim
217 words
A porphyrin compound of formula: ##STR4## wherein R 1 and R 2 are each --CH═CH 2 , --CH 2 CH 3 , --CH(O-lower alkanoyl)CH 3 ; --CH(OR)CH 3 or --CH(O-lower alkylene-OR)CH 3 ; R 3 is --H, --COOH, --COO-lower alkyl, --COO-lower alkylene-OR or --COO-lower alkylene-OOC--Z; R 4 is --H, -lower alkyl or -lower alkylene-OR; R is --H, --lower alkyl or a residue of a polyfunctional compound, said polyfunctional compound containing as one functional group carboxyl and at least one additional functional group which is selected from the group consisting of amino; hydroxy; mercapto and carboxyl; Z is a residue of the compound of the formula (I) excluding R 3 therefrom; A is --CH 2 -- or --CO--; and the dotted line from the gamma-position indicates no bonding or a single direct bond; and the dotted line between the 7- and 8-positions indicates the presence of a single bond or a double bond; and its complexes with a metal(s) in the porphine skeleton and/or at the residue of the polyfunctional compound, at least one or R 1 , R 2 , R 3 and R 4 being a group containing R which represents the residue of the polyfunctional compound and R 1 being capable of representing 1-iodoethyl in addition to said meanings when R 3 is --COO-lower alkylene-OOC--Z.
Claim 3
Dependent Claim
38 words
The porphyrin compound according to claim 1, wherein a is --CH 2 --, the dotted line from the gamma-position indicates no bodnding and the dotted line between the 7- and 8-positions indicates the presence of a double bond.
Claim 4
Dependent Claim
38 words
The porphyrin compound according to claim 1, wherein A is --CO--, the dotted line from the gamma-position indicates a single direct bond and th dotted line between the 7- and 8-positions indicates the presence of a single bond.
Claim 5
Dependent Claim
211 words
A porphyrin compound of the formula: ##STR5## wherein R 1 and R 2 are each --CH═CH 2 , --CH 2 CH 3 , --CH(O-lower alkanoyl)CH 3 , --CH(OR)CH 3 or --CH(O-lower alkylene-OR)CH 3 ; R 3 is --H, --COOH, --COO-lower alkyl, --COO-lower alkylene-OR or --COO-lower alkylene-OOC--Z; R 4 is --H, --lower alkyl or -lower alkylene --OR; R is --H, -lower alkyl or a residue of a polyfunctional compound, said polyfunctional compound containing as one functional group carboxyl and at least one additional functional group which is a chelate-forming group; Z is a residue of the compound of the formula (I) excluding R 3 therefrom; A is --CH 2 -- or --CO--; and the dotted line from the gamma-position indicates no bonding or a single direct bond; and the dotted line between the 7- and 8-positions indicates the presence of a single bond or a double bond; and its complexes with a metal(s) in the porphine skeleton and/or at the residue of the polyfunctional compound, at least one of R 1 , R 2 , R 3 and R 4 being a group containing R which represents the residue of the polyfunctional compound and R 1 being capable of representing 1-iodoethyl in addition to said meanings when R 3 is --COO-lower alkylene-OOC--Z.
Claim 6
Dependent Claim
211 words
A porphyrin compound of the formula: ##STR5## wherein R 1 and R 2 are each --CH═CH 2 , --CH 2 CH 3 , --CH(O-lower alkanoyl)CH 3 , --CH(OR)CH 3 or --CH(O-lower alkylene-OR)CH 3 ; R 3 is --H, --COOH, --COO-lower alkyl, --COO-lower alkylene-OR or --COO-lower alkylene-OOC--Z; R 4 is --H, --lower alkyl or -lower alkylene --OR; R is --H, -lower alkyl or a residue of a polyfunctional compound, said polyfunctional compound containing as one functional group carboxyl and at least one additional functional group which is a chelate-forming group; Z is a residue of the compound of the formula (I) excluding R 3 therefrom; A is --CH 2 -- or --CO--; and the dotted line from the gamma-position indicates no bonding or a single direct bond; and the dotted line between the 7- and 8-positions indicates the presence of a single bond or a double bond; and its complexes with a metal(s) in the porphine skeleton and/or at the residue of the polyfunctional compound, at least one of R 1 , R 2 , R 3 and R 4 being a group containing R which represents the residue of the polyfunctional compound and R 1 being capable of representing 1-iodoethyl in addition to said meanings when R 3 is --COO-lower alkylene-OOC--Z.
Claim 7
Dependent Claim
39 words
The porphyrin compound according to claim 4, wherein said polyfunctional compound is selected from the group consisting of ethylenediaminetetracetic acid. diethylenetriaminepentaacetic acid, 1,2-bis(o-amino-phenoxy) ethane-N,N,N',N'-tetracetic acid, 1,3diamoninopropan-2-ol-N,N,N',N'-tetraacetic acid, trans-1,2-cyclohexanediamine-N,N,N',N'-tetraacetic acid, N-hydroxyethylethylenediamine-N,N',N'- triacetic acid, ethylenediamine-N,N'-diacetic acid, iminodiacetic acid and ethylenediaminedi(o-hydroxyphenylacetic acid).
Claim 8
Dependent Claim
14 words
The porphyrin compound according to claim 5, wherein said polyfunctional compound is diethylenetriaminepentaacetic acid.
Claim 9
Dependent Claim
14 words
The porphyrin compound according to claim 5, wherein said polyfunctional compound is trans1,2-cyclohexanediamine-N,N,N',N'-tetraacetic acid.
Claim 10
Dependent Claim
15 words
The porphyrin compound according to claim 1, wherein said polyfunctional compound is an amino acid.
Claim 11
Dependent Claim
37 words
The porphyrin compound according to claim 8, wherein said amino acid is selected from the group consisting of glycine, cysteine, glutamic acid, alanine, cystine, asparagine, valine, methionine, glutamine, leucine, phenylalanine, isoleucine, serine, tryptophane, threonine and aspartic acid.
Claim 12
Dependent Claim
13 words
The porphyrin compound according to claim 9, wherein the amino acid is glycine.
Claim 13
Dependent Claim
14 words
The porphyrin compound according to claim 9, wherein the amino acid is glutamic acid.
Claim 14
Dependent Claim
19 words
The complex of the porphyrin compound according to claim 1, wherein the metal is present in the porphine skeleton.
Claim 15
Dependent Claim
23 words
The complex of the porphyrin compound according to claim 1, wherein the metal is present at the residue of the polyfunctional carboxyl compound.
Claim 16
Dependent Claim
28 words
The complex of the porphyrin compound according to claim 1, wherein the metals are present in the porphine skeleton and at the residue of the polyfunctional carboxyl compound.
Claim 17
Dependent Claim
31 words
The complex of the porphyrin compound according to claim 1, wherein the metals are chosen from Si, Mn, Fe, Co, Ni, Zn, Ga, In, Sn, Sm, Eu, Gd, Tc and Tl.
Claim 18
Dependent Claim
17 words
The complex of the porphyrin compound according to claim 1, wherein at least one metal is radioactive.
Claim 19
Dependent Claim
24 words
A radioactive diagnostic composition comprising carrier and the complex of the porphyrine compound according to claim 1, wherein at least one metal is radioactive.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-07-17 | 1993-01-16 | 1993-07-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-07-17 | 1997-01-16 | 1997-07-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-07-17 | 2001-01-16 | 2001-07-18 | $7700.00 | Window Closed / Lapsed |